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Key Points
• There is evidence that as we age the sensory signals that are generated from the bowel become attenuated and
while this is borne out by electrophysiological studies in rodents there is a paucity of mechanistic information
from humans.
• By recording directly the afferent impulse traffic in resected human colonic we have demonstrated attenuated
nerve activity with age that is associated with concurrent changes in nerve density, enterochromaffin cell
number and mucosal mast cells.
• These changes in key components of the gastrointestinal surveillance mechanisms has implications for our
understanding of the mechanisms underlying the increased prevalence of GI disorders in the elderly.
Abstract
Background Advanced age is associated with a reduc-
tion in clinical visceral pain perception. However, the
underlying mechanisms remain largely unknown. Pre-
vious studies have suggested that an abnormal inter-
play between mast cells, enterochromaffin (EC) cells,
and afferent nerves contribute to nociception in gas-
trointestinal disorders. The aim of this study was to
investigate how aging affects afferent sensitivity and
neuro-immune association in the human bowel.
Methods Mechanical and chemical sensitivity of
human bowel afferents were examined by ex vivo
afferent nerve recordings. Age-related changes in the
density ofmast cells, EC cells, sensory nerve terminals,
and mast cell-nerve micro-anatomical association
were investigatedbyhistological and immune staining.
Key Results Human afferents could be broadly classi-
fied into subpopulations displaying mechanical and
chemical sensitivity, adaptation, chemo-sensitization,
and recruitment. Interestingly human bowel afferent
nerve sensitivity was attenuated with age. The density
of substance P-immunoreactive (SP-IR) nerve varicosi-
ties was also reduced with age. In contrast, the density
of ileal and colonic mucosal mast cells was increased
with age, as was ileal EC cell number. An increased
proportion ofmast cellswas found in close apposition to
SP-IR nerves. Conclusions & Inferences Afferent sen-
sitivity in human bowel was reduced with advancing
age. Augmentation of mast cells and EC cell numbers
and the mast cell-nerve association suggest a compen-
satory mechanism for sensory neurodegeneration.
Keywords aging, EC cells, human bowel afferent,
mast cells.
Abbreviations: 5-HT (serotonin), 5-hydroxytryptamine;
AITC, allyl isothiocyanate; BK, bradykinin; CAP,
capsaicin; CgA, chromogranin A; EC cells, enterochro-
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dehydrogenase; IBS, irritable bowel syndrome; qPCR,
real-time quantitative polymerase chain reaction; SP,
substance P; TPH1, tryptophanhydroxylase1; TRP
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channels, transient receptor potential; TRPA1, tran-
sient receptor potential ankyrin receptor; TRPC, tran-
sient receptor potential canonical-related receptor
subfamily; TRPM, transient receptor potential melas-
tatin-related receptor subfamily; TRPV1, transient
receptor potential vanilloid 1 receptor.
The incidence and prevalence of a number of gastro-
intestinal (GI) tract disorders profoundly increase with
age.1,2 However, relatively little is known about how
aging alters sensory signaling from the gut. Previous
studies have shown that in humans, visceral pain
perception from the GI tract in response to distension
was significantly reduced with age.3,4 Moreover,
abdominal pain and nausea in response to a standard
nutrient challenge test (a test in which volunteers are
asked to ingest increasing amounts of a liquid nutrient)
is also diminished in the elderly.5 Experimental studies
with rodents have shown that the numbers of myen-
teric and submucosal neurones decline with age,6–9 and
that sympathetic innervation and vagal nerves deteri-
orate.10 A recent study from our laboratory found that
mechanosensation and serotonergic chemosensitvity
in the mouse intestine was significantly inhibited with
age.11 However, there are currently no equivalent
human data showing how aging affects sensory signal-
ing from the bowel. The interplay between mast cells,
enterochromaffin (EC) cells, and the sensory innerva-
tion of the gut wall is a key to normal neuro-immune
signaling. Aberrant signaling between these elements
may play a significant role in the etiology of functional
GI conditions such as irritable bowel syndrome (IBS).
For example, in IBS patients, we already know that
mast cell and EC cell numbers are elevated in the
colon,12 the severity of abdominal pain correlates with
increased serotonin release from the EC cell,13 and the
distance between the mast cells and nerve terminals is
reduced and correlates to increased abdominal pain.14
Moreover, clinical data show that the mast cell
stabilizer, disodium cromoglycate improves IBS symp-
toms.15 While neuro-immune signaling in the bowel
has been well studied, the effect that aging has on the
normal interaction between mast cells, EC cells, and
sensory nerves has yet to be established.
Our understanding of GI sensory function has
depended greatly on rodent studies. However, how this
translates to humans remains uncertain. There are
many examples of therapeutic agents developed using
animal models that have failed in the clinic. For
example, alosetron, a 5-HT3 receptor antagonist, was
approved for marketing to relieve symptoms of IBS but
was withdrawn 9 months later owing to serious
life-threatening adverse effects (U.S. Food and Drug
Administration, 2002). A number of other drugs have
also failed to show efficacy in clinical trials, such as
talnetant (NK3 receptor antagonist), GW876008 (corti-
cotropin-releasing factor-1 receptor antagonist), and
AZD7371 (5-HT1A receptor antagonist),
16,17 despite
promising data from animal studies.18–20 These failures
highlight a demand for translational research on human
tissue. Although ex vivo afferent recordings of the
rodent GI tract have been well established, very few
studies have looked at afferent signaling in man. To
address this, our group recently developed an ex vivo gut
preparation to record afferent activity from isolated
segments of thehumanbowel.These studieswereoneof
the first to report sensory nerve activity from human
tissue.21 The aim of this study was to examine patterns
of innervation, afferent nerve sensitivity, andmast cells,
EC cell localization in the aged human bowel.
MATERIAL AND METHODS
Ethical approval and donors
Specimens were obtained from 59 patients (35 male) aged between
24 and 88 with a median age of 67, who had undergone right or left
hemicolectomy at the Northern General Hospital NHS Founda-
tion Trust in Sheffield. Specimens were collected from patients
with a range of disease phenotypes (summarized in Table S1).
Tissues were always taken from the healthy tissue bordering the
disease area rather from the area of active disease. This was
confirmed by a pathologist at the time of collection. Informed
written consent was obtained from each participant. Studies were
performed according to the declaration of Helsinki and the BMJ
guideline on patient consent to publication. Experimental proce-
dures were approved by the South Humber Research Ethics
Committee (REC ref: 07/Q1105/4) and the Research Department
in Sheffield Teaching Hospitals (ref: STH14755).
Extracellular afferent nerve recording
Extracellular afferent recording were conducted using an ex vivo
preparation as previously described.21 Forty-five human bowel
specimens primarily from ileum and sigmoid colon were used.
Segments were opened longitudinally along the mesentery border
and pinned flat with mucosa uppermost in a tissue bath (volume
~100 mL) constantly perfused with gassed (5% CO2 and 95% O2)
Krebs buffer (composition, in mM: NaCl 120, KCl 5.9, MgSO4 1.2,
NaH2PO4 1.2, NaHCO3 15.4, glucose 11.5, and CaCl2 1.2) at
34 °C. Nerve bundles were identified in the mesentery and drawn
into a glass suction electrode attached to a Neurolog headstage
(NL100; Digitimer Ltd, Hertfordshire, UK). Afferent signals were
amplified (NL104), filtered (NL125 band pass filter), and recorded
on a computer via a power 1401 analog-to-digital interface and
Spike 2 software (Version 7; Cambridge Electronic Design,
Cambridge, UK).
After an equilibration period, the receptive field of each
afferent was identified by systematically probing the tissue using
a glass probe. Mechanosensitivity was examined by applying three
stimuli: probing (with calibrated von Frey hair 4, 10, and 60 g;
each probing was applied for 2 s and repeated at least 5 times with
© 2016 The Authors.
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a 3-s interval), fine mucosal stroking (1 or 4 g force), and stretch
(using forceps). Chemosensitivity was then examined by applying
selective agonists directly onto the receptive fields using a pipette.
Single unit analysis was performed offline using the spike sorting
function of Spike 2 to discriminate the afferent nerve activity of
individual units. Afferent activity is expressed as frequency per
second (impulse/s).
Histology and immunohistochemistry
Human bowel specimens were fixed in 4% PFA overnight at 4 °C.
For histological staining, fixed specimens were dehydrated in
graded ethanol (70%, 90%, 100%, and dried 100%) prior to
infiltration in freshly made catalyzed JB4 resin solution. Speci-
mens were then embedded in JB4 resin with accelerator, mounted
on aluminum stubs and sectioned at 2 lm using a microtome
(LKB 2218; LKB-Produkter, Bromma, Sweden). For immunohisto-
chemistry, fixed tissue was cryo-protected with 30% sucrose
overnight at 4 °C, embedded in OCT (53581; Bright Instrument
Company, Huntingdon, UK), and sectioned at 10 lm using a
cryostat (Bright Instrument Company).
Toluidine blue staining
Sections were stained with 0.1% toluidine blue for 3 min and
mounted with coverslips using DPX mounting medium. Three
populations of mast cells (mucosa, submucosa, and serosa) were
blindly quantified under a 209 objective with an Olympus BX51
(Tokyo, Japan) light microscope using an eyepiece graticule (area:
0.35 mm 9 0.35 mm = 0.1225 mm2). Ten random microscope
fields of mucosa and serosa and 20 random fields of submucosa
were quantified for each section. Data were expressed as number
of mast cells/mm2.
Immunohistochemical staining
Sectionswere incubatedwith a primary antibody forECcells (rabbit
antiserotonin, 1 : 50, [AHP522], AbD Serotec, Oxford, UK) or a
mixture of primary antibodies for mast cells (mouse antimast cell
tryptase, 1 : 1000, [Sc271095] Santa Cruz, Heidelberg, Germany)
and substance P (SP; rabbit anti-SP, 1 : 50, Abcam, ab24126)
overnight at 4 °C. After rinsing with PBS, slides were stained with
corresponding secondary antibodies, goat anti-rabbit conjugated to
Cy3 (1 : 400, [111-165-144], Jackson ImmunoResearch, West
Baltimore Pike, PA, USA) or a mixture of goat anti-mouse Cy3
(1 : 400, [115-166-003] Jackson ImmunoResearch, Baltimore West
Pike, PA, USA) and goat anti-rabbit FITC (1 : 400, [FI-1000] Vector
laboratories, Peterborough,UK), for 2 h at roomtemperature. Slides
were mounted with coverslips using mounting medium (Vector
H1200). Negative controls were performed by omitting the primary
antibody. Staining was observed under an Olympus BX51 micro-
scope. Imageswere captured using anOlympusColorView II digital
camera for offline quantification. Images were analyzed using
ImageJ software (1.43u; National Institutes of Health, Bethesda,
MD, USA) where applicable.
Substance P density was quantified as the area occupied by SP
as a percentage of the total area of mucosa. Enterochromaffin cell
number was counted and normalized to the area of mucosa. The
distance between a mast cell and its nearest SP-IR varicosity was
measured using ImageJ.
As a negative control for mast cell-SP association, image
flipping was performed. Prior to superimposing images for mast
cell staining and SP staining, one of the channels was flipped
horizontally. Measurement of mast cells-SP distances and distri-
bution analysis was performed to ensure that proximity was not
due to a random occurrence (Fig. S3).
H&E staining and electron microscopy
See supplementary methods (Data S1).
PCR
See supplementary methods (Table S2).
Drugs and compounds
All drugs, chemical compounds, and reagents were purchased
from Sigma-Aldrich (Dorset, UK) unless stated specifically.
Data analysis and statistics
All data are expressed as mean  SEM. Statistical significance
was confirmed using either a Student’s t-test or one-way ANOVA as
appropriate. p < 0.05 was considered as significant. To evaluate
the influence of aging, a linear regression test was performed. All
quantification was performed in a blinded manner. All statistical
analysis was performed using GraphPad Prism 5 (GraphPad
Software Inc., La Jolla, CA, USA).
RESULTS
Human bowel afferent recordings and
ultrastructure of recorded nerves
Afferent nerve firing was recorded in 20 of 45 speci-
mens, giving an overall success rate of 45%, of these
only 8 specimens were responsive to mechanical or
chemical stimulation. Success rate was not dependent
on the age of donor or the region of specimens (Fig. S1).
Structural integrity of the bowel wall was preserved
with normal morphology revealed by H&E staining
(Fig. S2A). Electron microscopy showed the mesenteric
nerve bundles to vary between 40 and 90 lm in
diameter, containing 1–3 fasciculi enveloped by a thin
perineurium. The majority of nerve fibers were
unmyelinated, although there were also a few myeli-
nated nerve fibers easily identified by their character-
istic dark sheath on the electron micrograph (Fig. S2C).
Characterization of mechanosensitive human
bowel afferents
A total of 34 afferent units from 20 specimens were
discriminated by Spike2 single unit analysis. Ten of
these units (29%) were mechanosensitive, differen-
tially responding to probing, mucosal stroking, and
stretch, and thus classified into mesenteric, serosal,
© 2016 The Authors.
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muscular, and mucosal afferents (Table 1 and Fig. 1).
Twenty-four units did not respond to probing, stroking,
or stretch and were termed unclassified.
One serosal unit responded to repeated probing with
a gradually reduced firing rate, indicating the nature of
mechano-adaptation. The unit also showed a dramatic
increase in firing rate to the incremental probing force
at 4, 10, and 60 g applied with a calibrated von Frey
hair (Fig. 1G). The mechanosensitivity to probing was
enhanced after treatment with 10 lM bradykinin (BK)
and 300 lM allyl isothiocyanate (AITC; Fig. 1H and I).
Chemosensitivity of human bowel afferents and
silent afferents
Once the receptive field had been identified, the
chemosensitivity was investigated by applying BK
(10 lM), capsaicin (CAP; 1 lM), AITC (300 lM) or 5-
HT (10 lM) directly onto the receptive field. Forty
percent (4/10) of mechanosensitive units responded to
either one or two chemical stimuli (Table 2 and Fig. 2).
Interestingly two colonic afferent units (one from a 49,
the other from a 67-year-old donor) that did not show
any firing activity before chemical stimuli were
recruited and started to fire after BK treatment
(Fig. 2E). These units were classified as ‘silent’ affer-
ents. However, they did not acquire mechanosensitiv-
ity after becoming active. Four units (2 serosal and 2
silent) showed a significant response to BK (basal vs
peak firing rate: 0.2  0.1 vs 1.9  0.5 impulses/s,
p < 0.05, paired t-test). The two BK-sensitive serosal
units also responded to AITC (basal vs peak firing rate:
0.3  0.2 vs 1.4  0.1 impulses/s). Two units (one
serosal, the other muscular) responded to CAP (basal vs
peak firing: 0.7  0.7 vs 4.2  2.7 impulses/s). The
muscular unit also responded to 5-HT (basal vs peak:
0.4 vs 1.6 impulses/s).
Age-related changes in human bowel afferent
sensitivity
Resting nerve activity was present in all preparations,
although a small proportion of units did not show basal
activity. With increasing age, average baseline firing
frequency was significantly decreased (Fig. 3B,
p < 0.05, linear regression, r2 = 0.304, N = 19). In
35% (12/34) of units, baseline firing exhibited a
bursting pattern (spontaneous burst firing). This was
also correlated with age such that the preparations
showing burst firing were from significantly younger
donors (mean age 47.2  4.1,N = 13) than preparations
without burst firing (mean age 63.9  2.2, N = 23,
Fig. 3C, p < 0.001, unpaired t-test). However, the
number of recorded units per bundle was not signifi-
cantly altered by age (Fig. 3D, p = 0.489, linear regres-
sion, r2 = 0.029, N = 19). The afferent response to
10 lM bradykinin was examined in preparations from
the sigmoid colon of a 42-, 55-, and 67-year-old donor.
In each case, bradykinin induced a robust increase in
nerve activity, however, the response profile was
blunted with increased age (Fig. 3E–H).
Afferent nerve density decreased in the aged
human colonic mucosa
Afferent nerve fibers were labeled with the sensory
neuronal marker SP. Positive staining was detected in
the mucosa, submucosa, myenteric plexus, and in
close vicinity to blood vessels. Substance P-immunor-
eactive nerve fibers were extensively distributed in the
lamina propria of mucosa, but not in the submucosa
and muscle layers. The density of mucosal SP was
significantly reduced with age (Fig. 4C, p < 0.01, linear
regression, r2 = 0.614, N = 10).
Closer association between mast cells and
afferent nerves with age
The micro-anatomical relationship between mast cells
and afferent nerve terminals in the human colonic
mucosa was investigated by double immunostaining
withmast cell tryptase andSPantibodies (Fig. 4DandE).
Analysis of proximity showed that more than 50% of
mast cells were located within 1 lm from a SP-IR
varicosity (Fig. 4F). Comparison of distribution patterns
between young and aged donors suggested that an
increased proportion of mast cells were in close apposi-
tion to SP-IR varicosities in aged samples (Fig. 4G–I).
Table 1 Characteristics of human bowel afferent mechanosensitivity
Classification Number of units (age) Spontaneous burst firing Probing Mucosal stroking Stretch
Mesenteric afferent 2 (24, same donor) Yes Yes No No
Serosal afferent 5 (42, 53, 55, 67, 72) 1: yes 4: no Yes No No
Muscular afferent 2 (49, 77) 1: yes 1: no Yes No Yes
Mucosal afferent 1 (42) Yes Yes Yes No
Unclassified 24 (median 66, range: 24–77) 7: yes 17: no No No No
© 2016 The Authors.
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Figure 1 Extracellular afferent nerve recordings of the human bowel. (A and B) Photographs showing a human gut preparation and dissection of a
nerve bundle, (C) Representative traces showing spontaneous burst firing (58-year-old, ileum), (D) afferent response to probing (77-year-old, colon), (E)
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Mast cell density increased in the aged mucosa
Mast cells stained with toluidine blue were identified
by their red-purple cytoplasmic metachromatic granu-
lar content and blue nuclei (Fig. 5A–F). Mast cells were
detected throughout the human bowel wall with a
greater density close to the muscularis mucosa. Occa-
sionally some positive cells were also identified in the
connective tissue and blood vessels running through
muscle layer. The density of mucosal mast cells was
significantly higher than in the submucosa and serosa
in both small intestine (p < 0.001, one-way ANOVA,
N = 9) and colon (p < 0.0001, N = 15, Fig. 5G). Muco-
sal but not submucosal or serosal mast cell density was
positively correlated with increased age in both the
ilium (Fig. 5H, p < 0.05, r2 = 0.606, linear regression,
N = 8) and large intestine (colon and rectum; Fig. 5I,
p < 0.05, r2 = 0.413, N = 14).
EC cell density increased in aged human ileal
mucosa
Serotonin immunoreactivity was used as a marker for
EC cells. Positive cells had a classical conical shape
and were relatively concentrated in the small and large
intestinal crypts (Fig. 6A–F). Density in the ileum
(p < 0.05, r2 = 0.528, linear regression, N = 10), but not
colon (p = 0.848, r2 = 0.003, N = 16) was positively
correlated with advancing age. Consistently, serotonin
immunoreactivity was also correlated with mast cell
density in the ileum (Fig. 6I, p < 0.05, r2 = 0.818,
N = 6) but not colon (Fig. 6J, p = 0.226, r2 = 0.201,
N = 9).
Gene expression in the aged human bowel
Gene expression for 7 transient receptor potential (TRP)
channels (TRPA1, TRPC4, TRPC6, TRPM2, TRPM4,
TRPM8, TRPV1) and 2 EC cell markers (Chromogranin
A, CgA and tryptophanhydroxylase1, TPH1) was exam-
ined using PCR. The highest expression was found for
TRPA1, TRPM4, and CgA. The expression of TRPA1
and TRPV1 in the ileum was significantly greater than
in the colon suggesting regional variation, however,
when expression in young tissues (<65 years old) was
compared to expression in older tissues (>65 years old)
no significant difference was seen (Fig S4).
DISCUSSION
This study provides the first evidence that sensory firing
from the human bowel is attenuated with age. Attenu-
ation was concurrent with a decrease in the sensory
nervemarker SP, but an increase inmast cell and ECcell
numbers. Interestingly, the anatomical proximity of
mast cells and SP expressing afferent nerves was
increased. Together these data suggest that aging alters
sensory and neuro-immune signaling in the human gut.
Characterization of human bowel afferent nerves
and changes associated with aging
To date very few studies have attempted to record from
human afferents. In the first part of this study, we
conducted a series of afferent nerve recordings using
human tissues. Our first task was to characterize the
afferent nerve phenotype in man and investigate how
this changes as a result of age.
Many previous studies have investigated afferent
signaling using in vivo and in vitro animal models, this
has led to a classification of afferents depending on their
sensitivity to mechanical stimuli and the location of
the receptive fields. Previously, mechanosensitive
nerves have been classified into five subpopulations:
mesenteric, serosal, muscular, mucosal, and muscular/
mucosal afferents using colonic tissues from the rat22 or
mouse.23,24 In this study using mechanical stimulus as
a method of classification (probing, stretch, and muco-
sal stroking), the same subpopulations were identified.
Interestingly, we also identified a high proportion of
mechanically insensitive afferents (71%). This propor-
tion was much higher than what has previously been
reported for pelvic (23%) and lumbar splanchnic (33%)
afferents innervating mouse colorectum24 suggesting
that while some functional characteristics of gut affer-
ents might be species independent, there might still be
some species-related differences between human and
mouse that remain to be identified.
In our characterization, we also identified two
mechanically insensitive units which were recruited
following application of bradykinin. This type of
afferent has previously been identified as a silent
nociceptor, a fiber, which only fires following
Table 2 Characteristics of human bowel afferent chemosensitivity
Classification
Responsive
unit (age)
Drugs
BK
(10 lM)
CAP
(1 lM)
AITC
(300 lM)
5-HT
(10 lM)
Serosal
afferent
1 (55) Yes No Yes No
1 (42) Yes No Yes NT
1 (53) No Yes No NT
Silent
afferent
1 (67) Yes No No NT
1 (49) Yes No No NT
Muscular
afferent
1 (77) NT Yes NT Yes
NT, not tested.
© 2016 The Authors.
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sensitization after exposure to an inflammatory medi-
ator.24,25 A previous systematic study revealed that
about 30% of afferents innervating the mouse colorec-
tum are normally mechanically insensitive, but a
proportion of them acquire mechanosensitivity after
application of an inflammatory soup.24 Silent afferents
may be important contributors to the development and
maintenance of hypersensitive states; therefore, iden-
tifying them and characterizing them in the human
might have significance to understanding the patho-
genesis of many GI disorders.
We also observed other functional characteristics
that have only previously been demonstrated in ani-
mals.23,26,27 These included graded responses to prob-
ing, fast adaptation to repeated stimulation and
mechanical sensitization induced by bradykinin, and
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Figure 2 Chemosensitivity of human bowel afferents. Representative traces showing the afferent response to application of (A) 10 lMBK, (B) 300 lM
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the TRPA1 agonist AITC. A proportion of the afferent
units that we recorded exhibited chemosensitivity,
responding to CAP, bradykinin, AITC, or 5-HT. Inter-
estingly, four of these chemosensitive afferent units
also responded to mechanical stimuli, something
characteristic of a polymodal nociceptor. Unfortu-
nately due to tissue availability, extensive characteri-
zation of human bowel afferents was not feasible.
However, it is clear that many of the functional
characteristics previously identified in animals were
also present in our human bowel recordings.
In a recent study from our laboratory the effect of
aging on mouse afferent nerve sensitivity was mea-
sured. We found that aging correlated with a reduction
in sensory firing and altered serotonergic signaling.11 A
similar decline in afferent sensitivity was also observed
for the human bowel although sample size was limited
by the availability of tissue. Basal nerve activity was
reduced with age, less burst firing was seen in prepa-
rations from older people and sensitivity to the
inflammatory mediator bradykinin was blunted. While
this is by no means conclusive evidence, these data do
support the concept that aging is associated with
reduced sensory signaling. This may contribute to
reduced pain signaling in the elderly.
Previous morphological studies suggest that neu-
ronal numbers in the enteric nervous system decline
with age.6,9,28,29 Sympathetic and vagal innervation in
the gut also show signs of degeneration10,30 and a
reduction in the size or number of primary neurons
in the mammalian nodose and dorsal root ganglia
(DRG) have been described.31 In this study, we
measured sensory nerve density using SP as a marker,
and found significant attenuation in immunoreactiv-
ity in correlation with increasing age. Two previous
studies also reported a decline in SP-positive nerve
fibers in the circular muscle of the aged guinea-pig
colon32 and the DRG of the aged rat.33 While we
recognize that this is just one marker of afferent
nerve endings, these data suggest that either neu-
ropeptide content in the afferent terminal is reduced
with age or that aging induces neurodegeneration in
the gut wall. Clearly further studies are still required
to fully identify how aging alters innervation patters
in the bowel, however, sensory neurodegeneration
may explain the decreased sensitivity observed in our
afferent nerve recordings.
Neuro-immune interactions and aging
Altered neuro-immune interactions might also play a
role in changing afferent sensitivity in the aged bowel.
Our data revealed an age-related increase in the density
of mucosal mast cells and EC cells in the gut wall. It
has been proposed previously that increased circulating
levels of pro-inflammatory cytokines including
interleukin (IL)-1, IL-6, tumor necrosis factor-alpha,
and IL-12, interferon-alpha/beta promote a low-grade
chronic systemic pro-inflammatory state in the
elderly.34–36 This state is associated with enhanced
immune cell infiltration and could explain the increase
in mast cell numbers observed in this study.
Previous studies have reported an anatomical asso-
ciation between mast cells and SP-positive nerves in a
variety of rodent organs, human skin, and the colon of
IBS patients.37–40 Interestingly, when we looked at the
proximity of mast cells to the SP-positive fibers in our
human tissues, we found a significant correlation with
age, whereby mast cells were in closer association with
the nerve fibers in tissues from older donors compared
to those from younger donors. In our analysis, we
normalized the absolute number of cells to the relative
distribution excluding the possibility that this closer
association was only secondary to increased cell num-
ber. Why this mast cells-nerve association is altered
with age remains unclear, however, it is tempting to
speculate that with aging, mast cells could migrate
toward the nerve fibers as a compensatory mechanisms
due to a reduction in innervation.
The EC cell, releases 5HT to regulate motility,
secretion, and neuronal activity. In our previous study
looking at the effect of aging in the mouse intestine,
we found EC cell numbers were elevated but that
afferent sensitivity to 5-HT was reduced. In this study,
numbers of EC cells in the ileum but not the colon
were also elevated with age. As with the increased
mast cell number, increased EC cell density might also
be a consequence of accumulation of inflammatory
events. It has been suggested that EC cell hyperplasia
and reduced serotonin transporter (SERT) expression
may persist in the gut as a consequence of short-term
inflammation.41 Indeed, in this study, we found a
positive correlation between mast cell number and the
density of EC cells in the ileum. However, our PCR
data found that the expression of TPH1 was not
changed suggesting that 5HT bioavailability is not
altered with age.
Limitations and advantages of using human
tissue
The vast majority of what we know about the function
of the gut has been gained from animal studies,
however, very little translational research looking at
human GI physiology has been conducted. In this
study, we wanted to investigate how afferent signaling
© 2016 The Authors.
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and neuro-immune function was affected by age in
human tissues. Although studies on human tissues
offer the distinct advantage of looking directly at the
function of the human bowel, key disadvantages and
limitations exist. Firstly, conducting the ex vivo extra-
cellular afferent recordings using human tissues proved
to be extremely technically challenging. In a typical
recording of mouse jejunum, 10–15 afferent units can
be simultaneously recorded, however, in human tis-
sues, the recording sites were very close to the gut wall
and typically only 1 or 2 units were recorded. Secondly,
the region of the gut from where the tissues were taken
was unpredictable (i.e. ileum, colon, or rectum) and
tissue variability was an issue, finally variations in
donor age, gender, genetic background, and medical
history add complexity to the data. As previous studies
Figure 4 Density of SP-positive nerve fibers and the mast cell-SP anatomical relationship in the human colonic mucosa. (A and B) representative
images showing SP-IR (green) nerve fibers running through the laminar propria of colonic mucosa (54- and 80-year-old donors, respectively). (C)
Density of SP in colonic mucosa was reduced with advanced age (p < 0.01, r2 = 0.614, linear regression, N = 10). (D) Representative image showing
tryptase-positive mast cells (red) and SP-IR varicosities (green) in the colonic mucosa. (E) Magnified image showing the close apposition between mast
cells and SP. (F) Frequency distribution pattern of distances between mast cell and SP (N = 9). (G) A representative comparison of the frequency
distribution patterns in 54- and 80-year-old donors. (H) The percentage of mast cells within 1 lm distance to SP was increased with age (p < 0.01,
r2 = 0.741, linear regression, N = 9) but reduced within 8–9 lm distance (I: p < 0.01, r2 = 0.684, N = 9). LP, laminar propria; MM, muscularis
mucosae. Scale bar = 20 lm (A, B), 50 lm (D), 10 lm (E).
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have revealed alterations in mast cell, EC cells, and SP
with IBS, understanding donor symptomology might
also influence the evaluation of age-related changes in
the gut. Although our specimens were taken from the
‘safe margins’ and appeared to be morphologically
normal, the changes we observed could have been
influenced by disease phenotype. Also outside our
control was any ongoing or previous treatment patients
may have been receiving.
CONCLUSIONS
This study is the first to provide insight into the
functional and morphological changes in the sensory
function of human bowel with age. Although reliant on
relatively small sample sizes, and taking into consid-
eration all the limitations described, we find that the
aged bowel has reduced afferent sensitivity and
increased immune cell numbers suggesting altered
neuro-immune function occurs with aging. Our find-
ings clearly show some key alterations in the human
gut. However, further studies are now required to
provide detailed mechanistic insight.
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Figure S2 Tissue integrity and ultrastructure of recorded nerves.
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